| Primary |
| Anxiety |
50.0% |
| Depression |
25.0% |
| Epilepsy |
25.0% |
|
| Suicidal Ideation |
50.0% |
| Nausea |
25.0% |
| Ventricular Arrhythmia |
25.0% |
|
| Secondary |
| Schizophrenia |
38.5% |
| Anxiety |
15.4% |
| Hallucination |
15.4% |
| Attention Deficit/hyperactivity Disorder |
7.7% |
| Plasma Cell Myeloma |
7.7% |
| Thinking Abnormal |
7.7% |
| Tuberous Sclerosis |
7.7% |
|
| Oedema Peripheral |
14.3% |
| Restlessness |
14.3% |
| Stomatitis |
14.3% |
| Suicidal Ideation |
14.3% |
| Tachycardia |
14.3% |
| Vaginal Haemorrhage |
14.3% |
| Yawning |
14.3% |
|
| Concomitant |
| Multiple Sclerosis |
24.4% |
| Drug Use For Unknown Indication |
12.7% |
| Plasma Cell Myeloma |
11.7% |
| Chronic Myeloid Leukaemia |
8.1% |
| Osteoporosis |
6.1% |
| Gait Disturbance |
5.6% |
| Type 2 Diabetes Mellitus |
4.6% |
| Hepatitis C |
3.6% |
| Osteopenia |
3.6% |
| Relapsing-remitting Multiple Sclerosis |
3.6% |
| Immunodeficiency Common Variable |
2.5% |
| Osteoporosis Prophylaxis |
2.0% |
| Product Used For Unknown Indication |
2.0% |
| Small Cell Lung Cancer Stage Unspecified |
2.0% |
| Actinic Keratosis |
1.5% |
| Breast Cancer |
1.5% |
| Nephrogenic Anaemia |
1.5% |
| Acute Myeloid Leukaemia |
1.0% |
| Age-related Macular Degeneration |
1.0% |
| Bone Cancer |
1.0% |
|
| Vision Blurred |
10.5% |
| Rash |
7.4% |
| Vomiting |
7.4% |
| White Blood Cell Count Decreased |
7.4% |
| Urinary Tract Infection |
6.3% |
| Fatigue |
5.3% |
| Nausea |
5.3% |
| Pain In Extremity |
5.3% |
| Stress Fracture |
5.3% |
| Weight Decreased |
5.3% |
| Pancreatitis |
4.2% |
| Pneumonia |
4.2% |
| Somnolence |
4.2% |
| Tremor |
4.2% |
| Weight Increased |
4.2% |
| Anaphylactic Reaction |
3.2% |
| Convulsion |
3.2% |
| Visual Impairment |
3.2% |
| Abdominal Pain |
2.1% |
| Device Breakage |
2.1% |
|
